Time trends in tumour thickness vary in subgroups: analysis of 6475 patients by age, tumour site and melanoma subtype

An elevated tumour thickness is strongly associated with an increased risk of mortality in melanoma patients. In the last few decades, an overall decrease of the tumour thickness to prognostically more favourable levels has been observed in several countries. Nevertheless, it is not clear whether this positive time trend occurred uniformly in specific subgroups of melanoma patients. Therefore, we aimed to assess time trends of tumour thickness by age group, tumour site and melanoma subtype. The study population consisted of 6475 patients with histologically proven primary invasive cutaneous melanomas seen at the Department of Dermatology and Allergology at the Ludwig-Maximilian-University Munich between 1977 and 2000. Age-adjusted time trends were assessed using linear and logistic regression analysis. Overall, a positive time trend with a decreasing tumour thickness was observed during the observation period in most subgroups. However, no significant time trend was observed in patients with a melanoma on the feet or with a nodular or acrolentiginous melanoma. The almost constant high tumour thickness of these patients might be caused by underaddressing the specific traits of these melanomas in earlier prevention campaigns. An important goal for the upcoming years should consist of a positive time trend with a decreasing tumour thickness in these subgroups.

[1]  L. Dennis,et al.  Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry. , 1999, Archives of dermatology.

[2]  A. Blum,et al.  Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatment , 1999, The British journal of dermatology.

[3]  B. Armstrong,et al.  Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983–1996 , 2001, International journal of cancer.

[4]  Eric R. Ziegel,et al.  Generalized Linear Models , 2002, Technometrics.

[5]  P. Altmeyer,et al.  A local education campaign on early diagnosis of malignant melanoma , 1993, European Journal of Epidemiology.

[6]  Claus Garbe,et al.  Development of prognostic factors and survival in cutaneous melanoma over 25 years , 2005, Cancer.

[7]  G. Plewig,et al.  Disease progression in patients with thin cutaneous melanomas (tumour thickness ≤ 0·75 mm): clinical and epidemiological data from the Tumour Center Munich 1977–98 , 2003, The British journal of dermatology.

[8]  G. Plewig,et al.  Factors associated with a high tumour thickness in patients with melanoma , 2007, The British journal of dermatology.

[9]  C. Bartoli,et al.  Metamorphosis of melanoma. Trends in size and thickness of cutaneous melanoma over one decade at the Istituto Nazionale Tumori, Milan , 2008, Tumori.

[10]  TR Hawkins.  Re-reading Silent Spring. , 1994, Environmental health perspectives.

[11]  David Polsky,et al.  Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. , 2004, JAMA.

[12]  C. la Vecchia,et al.  Recent declines in worldwide mortality from cutaneous melanoma in youth and middle age , 1999, International journal of cancer.

[13]  Donald R. Miller,et al.  Early detection of thick melanomas in the United States: beware of the nodular subtype. , 2005, Archives of dermatology.

[14]  Robert C. Burton,et al.  Non‐metastasizing melanoma? , 1998, Journal of surgical oncology.

[15]  J. Doré,et al.  Time trends of cutaneous melanoma in Queensland, Australia and Central Europe , 2002, Cancer.

[16]  J C Briggs,et al.  Cutaneous melanoma. , 1993, Journal of the American Academy of Dermatology.

[17]  J. Hunter,et al.  Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group. , 1992, Lancet.

[18]  R. Marks.  Two decades of the public health approach to skin cancer control in Australia: Why, how and where are we now? , 1999, The Australasian journal of dermatology.

[19]  D. Forman,et al.  Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993 and 2003 , 2008, International journal of cancer.

[20]  F. Bray,et al.  Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: Rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in Scandinavia , 2003, International journal of cancer.

[21]  P. Boyle,et al.  Mortality from cutaneous melanoma: evidence for contrasting trends between populations , 2000, British Journal of Cancer.

[22]  R. Corona,et al.  Time trends in features of cutaneous melanoma at diagnosis: central-south Italy, 1962-1991. , 1993, Annali dell'Istituto Superiore di Sanità.

[23]  M. Nicolson,et al.  Incidence of and survival from malignant melanoma in Scotland: an epidemiological study , 2002, The Lancet.

[24]  R. MacKie,et al.  Cutaneous malignant melanoma, Scotland, 1979-89 , 1992, The Lancet.

[25]  C. Balch,et al.  A Multifactorial Analysis of Melanoma: Prognostic Histopathological Features Comparing Clark's and Breslow's Staging Methods , 1978, Annals of surgery.

[26]  D. Lipsker.  Growth rate, early detection, and prevention of melanoma: melanoma epidemiology revisited and future challenges. , 2006, Archives of dermatology.

[27]  Gerard J Fitzsimmons,et al.  From the Australian Institute of Health and Welfare , 2014, Communicable diseases intelligence quarterly report.

[28]  M. Nicolson,et al.  Melanoma incidence and mortality in Scotland 1979–2003 , 2007, British Journal of Cancer.

[29]  R. MacKie,et al.  Audit of public education campaign to encourage earlier detection of malignant melanoma. , 1992, BMJ.

[30]  Rory Wolfe,et al.  Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas. , 2006, Archives of dermatology.

[31]  D. Miller,et al.  Update on the incidence and mortality from melanoma in the United States. , 1999, Journal of the American Academy of Dermatology.

[32]  Gernot Rassner,et al.  Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients , 1995, Cancer.

[33]  O. Gefeller,et al.  Public awareness of malignant melanoma risk factors in Germany. , 1997, Journal of epidemiology and community health.

[34]  A. Stang,et al.  Site- and gender-specific time trend analyses of the incidence of skin melanomas in the former German Democratic Republic (GDR) including 19351 cases. , 2003, European journal of cancer.